CONGENITAL MYASTHENIC SYNDROME

This adverse event was reported 21 times

CONGENITAL MYASTHENIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PYRIDOSTIGMINE BROMIDE ORAL 14 0.0039
1 VILOXAZINE HYDROCHLORIDE 1 0.0008
2 AMIFAMPRIDINE PHOSPHATE 2 0.0007
3 PYRIDOSTIGMINE BROMIDE 5 0.0007
4 AZATHIOPRINE 2 0.0000
5 PREDNISOLONE ORAL SOLUTION 4 0.0000
6 ADALIMUMAB-FKJP 1 0.0000
7 ADALIMUMAB-AATY 1 0.0000
8 ADALIMUMAB-ADAZ 1 0.0000
9 LEVOFLOXACIN 1 0.0000
See all drugs enriched for association with CONGENITAL MYASTHENIC SYNDROME